Skip to main content
NCBI home page
Transactions of the American Clinical and Climatological Association logoLink to Transactions of the American Clinical and Climatological Association
. 1996;107:99–114.

The role of prostaglandins in gastric mucosal protection.

D E Wilson 1
PMCID: PMC2376552  PMID: 8725564

Full text

PDF
99

Images in this article

102FIG. 2
on p.102

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahlquist D. A., Dozois R. R., Zinsmeister A. R., Malagelada J. R. Duodenal prostaglandin synthesis and acid load in health and in duodenal ulcer disease. Gastroenterology. 1983 Sep;85(3):522–528. [PubMed] [Google Scholar]
  2. Armstrong C. P., Blower A. L. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. Gut. 1987 May;28(5):527–532. doi: 10.1136/gut.28.5.527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bahari H. M., Ross I. N., Turnberg L. A. Demonstration of a pH gradient across the mucus layer on the surface of human gastric mucosa in vitro. Gut. 1982 Jun;23(6):513–516. doi: 10.1136/gut.23.6.513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brown J. F., Keates A. C., Hanson P. J., Whittle B. J. Nitric oxide generators and cGMP stimulate mucus secretion by rat gastric mucosal cells. Am J Physiol. 1993 Sep;265(3 Pt 1):G418–G422. doi: 10.1152/ajpgi.1993.265.3.G418. [DOI] [PubMed] [Google Scholar]
  5. Caldwell J. R., Roth S. H., Wu W. C., Semble E. L., Castell D. O., Heller M. D., Marsh W. H. Sucralfate treatment of nonsteroidal anti-inflammatory drug-induced gastrointestinal symptoms and mucosal damage. Am J Med. 1987 Sep 28;83(3B):74–82. doi: 10.1016/0002-9343(87)90832-1. [DOI] [PubMed] [Google Scholar]
  6. DAVENPORT H. W., WARNER H. A., CODE C. F. FUNCTIONAL SIGNIFICANCE OF GASTRIC MUCOSAL BARRIER TO SODIUM. Gastroenterology. 1964 Aug;47:142–152. [PubMed] [Google Scholar]
  7. Dahlén S. E., Björk J., Hedqvist P., Arfors K. E., Hammarström S., Lindgren J. A., Samuelsson B. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. Proc Natl Acad Sci U S A. 1981 Jun;78(6):3887–3891. doi: 10.1073/pnas.78.6.3887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dajani E. Z., Driskill D. R., Bianchi R. G., Collins P. W., Pappo R. SC-29333: a potent inhibitor of canin gastric secretion. Am J Dig Dis. 1976 Dec;21(12):1049–1057. doi: 10.1007/BF01071862. [DOI] [PubMed] [Google Scholar]
  9. DuBois R. N., Awad J., Morrow J., Roberts L. J., 2nd, Bishop P. R. Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester. J Clin Invest. 1994 Feb;93(2):493–498. doi: 10.1172/JCI116998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ehsanullah R. S., Page M. C., Tildesley G., Wood J. R. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine. BMJ. 1988 Oct 22;297(6655):1017–1021. doi: 10.1136/bmj.297.6655.1017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Elliott S. N., McKnight W., Cirino G., Wallace J. L. A nitric oxide-releasing nonsteroidal anti-inflammatory drug accelerates gastric ulcer healing in rats. Gastroenterology. 1995 Aug;109(2):524–530. doi: 10.1016/0016-5085(95)90341-0. [DOI] [PubMed] [Google Scholar]
  12. Euler A. R., Safdi M., Rao J., Jaszewski R., Welsh J., Le V., Raskin J., Fleischmann R., Razzaque M., Champion C. A report of three multiclinic trials evaluating arbaprostil in arthritic patients with ASA/NSAID gastric mucosal damage. The Upjohn Company Arbaprostil ASA/NSAID Gastric Mucosal Damage Treatment Study Groups. Gastroenterology. 1990 Jun;98(6):1549–1557. doi: 10.1016/0016-5085(90)91089-o. [DOI] [PubMed] [Google Scholar]
  13. Euler A. R., Safdi M., Rao J., Jaszewski R., Welsh J., Le V., Raskin J., Fleischmann R., Razzaque M., Champion C. A report of three multiclinic trials evaluating arbaprostil in arthritic patients with ASA/NSAID gastric mucosal damage. The Upjohn Company Arbaprostil ASA/NSAID Gastric Mucosal Damage Treatment Study Groups. Gastroenterology. 1990 Jun;98(6):1549–1557. doi: 10.1016/0016-5085(90)91089-o. [DOI] [PubMed] [Google Scholar]
  14. Graham D. Y., Agrawal N. M., Roth S. H. Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial. Lancet. 1988 Dec 3;2(8623):1277–1280. doi: 10.1016/s0140-6736(88)92892-9. [DOI] [PubMed] [Google Scholar]
  15. Griffin M. R., Ray W. A., Schaffner W. Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons. Ann Intern Med. 1988 Sep 1;109(5):359–363. doi: 10.7326/0003-4819-109-5-359. [DOI] [PubMed] [Google Scholar]
  16. Herschman H. R. Regulation of prostaglandin synthase-1 and prostaglandin synthase-2. Cancer Metastasis Rev. 1994 Dec;13(3-4):241–256. doi: 10.1007/BF00666095. [DOI] [PubMed] [Google Scholar]
  17. Hillier K., Smith C. L., Jewell R., Arthur M. J., Ross G. Duodenal mucosa synthesis of prostaglandins in duodenal ulcer disease. Gut. 1985 Mar;26(3):237–240. doi: 10.1136/gut.26.3.237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hinsdale J. G., Engel J. J., Wilson D. E. Prostaglandin E in peptic ulcer disease. Prostaglandins. 1974 Jun 25;6(6):495–500. doi: 10.1016/s0090-6980(74)80059-6. [DOI] [PubMed] [Google Scholar]
  19. Hla T., Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7384–7388. doi: 10.1073/pnas.89.16.7384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Holtzman M. J., Turk J., Shornick L. P. Identification of a pharmacologically distinct prostaglandin H synthase in cultured epithelial cells. J Biol Chem. 1992 Oct 25;267(30):21438–21445. [PubMed] [Google Scholar]
  21. Isenberg J. I., Hogan D. L., Selling J. A., Koss M. A. Duodenal bicarbonate secretion in humans. Role of prostaglandins. Dig Dis Sci. 1986 Feb;31(2 Suppl):130S–130S. doi: 10.1007/BF01309337. [DOI] [PubMed] [Google Scholar]
  22. Isenberg J. I., Smedfors B., Johansson C. Effect of graded doses of intraluminal H+, prostaglandin E2, and inhibition of endogenous prostaglandin synthesis on proximal duodenal bicarbonate secretion in unanesthetized rat. Gastroenterology. 1985 Jan;88(1 Pt 2):303–307. doi: 10.1016/s0016-5085(85)80184-0. [DOI] [PubMed] [Google Scholar]
  23. Johnson L. R., Guthrie P. Effect of cholecystokinin and 16,16-dimethyl prostaglandin E2 on RNA and DNA of gastric and duodenal mucosa. Gastroenterology. 1976 Jan;70(1):59–65. [PubMed] [Google Scholar]
  24. Jones D. A., Carlton D. P., McIntyre T. M., Zimmerman G. A., Prescott S. M. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J Biol Chem. 1993 Apr 25;268(12):9049–9054. [PubMed] [Google Scholar]
  25. Karim S. M., Carter D. C., Bhana D., Ganesan P. A. Effect of orally administered prostaglandin E 2 and its 15-methyl analogues on gastric secretion. Br Med J. 1973 Jan 20;1(5846):143–146. doi: 10.1136/bmj.1.5846.143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Konturek S. J., Radecki T., Brzozowski T., Piastucki I., Dembiński A., Dembińska-Kieć A., Zmuda A., Gryglewski R., Gregory H. Gastric cytoprotection by epidermal growth factor. Role of endogenous prostaglandins and DNA synthesis. Gastroenterology. 1981 Sep;81(3):438–443. [PubMed] [Google Scholar]
  27. Lacy E. R., Ito S. Microscopic analysis of ethanol damage to rat gastric mucosa after treatment with a prostaglandin. Gastroenterology. 1982 Sep;83(3):619–625. [PubMed] [Google Scholar]
  28. Levi S., Goodlad R. A., Lee C. Y., Stamp G., Walport M. J., Wright N. A., Hodgson H. J. Inhibitory effect of non-steroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing. Lancet. 1990 Oct 6;336(8719):840–843. doi: 10.1016/0140-6736(90)92341-e. [DOI] [PubMed] [Google Scholar]
  29. Lubawy W. C., Culpepper B. T., Valentovic M. A. Alterations in prostacyclin and thromboxane formation by chronic cigarette smoke exposure: temporal relationships and whole smoke vs. gas phase. J Appl Toxicol. 1986 Apr;6(2):77–80. doi: 10.1002/jat.2550060202. [DOI] [PubMed] [Google Scholar]
  30. Manniche C., Malchow-Møller A., Andersen J. R., Pedersen C., Hansen T. M., Jess P., Helleberg L., Rasmussen S. N., Tage-Jensen U., Nielsen S. E. Randomised study of the influence of non-steroidal anti-inflammatory drugs on the treatment of peptic ulcer in patients with rheumatic disease. Gut. 1987 Feb;28(2):226–229. doi: 10.1136/gut.28.2.226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Masferrer J. L., Zweifel B. S., Manning P. T., Hauser S. D., Leahy K. M., Smith W. G., Isakson P. C., Seibert K. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3228–3232. doi: 10.1073/pnas.91.8.3228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Masuda E., Kawano S., Nagano K., Tsuji S., Takei Y., Tsujii M., Oshita M., Michida T., Kobayashi I., Nakama A. Endogenous nitric oxide modulates ethanol-induced gastric mucosal injury in rats. Gastroenterology. 1995 Jan;108(1):58–64. doi: 10.1016/0016-5085(95)90008-x. [DOI] [PubMed] [Google Scholar]
  33. McCready D. R., Clark L., Cohen M. M. Cigarette smoking reduces human gastric luminal prostaglandin E2. Gut. 1985 Nov;26(11):1192–1196. doi: 10.1136/gut.26.11.1192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Meade E. A., Smith W. L., DeWitt D. L. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem. 1993 Mar 25;268(9):6610–6614. [PubMed] [Google Scholar]
  35. Moncada S., Palmer R. M., Higgs E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991 Jun;43(2):109–142. [PubMed] [Google Scholar]
  36. Palmer R. M., Ferrige A. G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987 Jun 11;327(6122):524–526. doi: 10.1038/327524a0. [DOI] [PubMed] [Google Scholar]
  37. Peskar B. M. Role of cysteinyl leukotrienes in gastric mucosal damage in rats. Adv Prostaglandin Thromboxane Leukot Res. 1989;19:552–555. [PubMed] [Google Scholar]
  38. Pique J. M., Whittle B. J., Esplugues J. V. The vasodilator role of endogenous nitric oxide in the rat gastric microcirculation. Eur J Pharmacol. 1989 Dec 19;174(2-3):293–296. doi: 10.1016/0014-2999(89)90324-5. [DOI] [PubMed] [Google Scholar]
  39. Quimby G. F., Bonnice C. A., Burstein S. H., Eastwood G. L. Active smoking depresses prostaglandin synthesis in human gastric mucosa. Ann Intern Med. 1986 May;104(5):616–619. doi: 10.7326/0003-4819-104-5-616. [DOI] [PubMed] [Google Scholar]
  40. Rainsford K. D. Mechanisms of gastrointestinal damage by NSAIDS. Agents Actions Suppl. 1993;44:59–64. [PubMed] [Google Scholar]
  41. Rainsford K. D. The effects of 5-lipoxygenase inhibitors and leukotriene antagonists on the development of gastric lesions induced by nonsteroidal antiinflammatory drugs in mice. Agents Actions. 1987 Aug;21(3-4):316–319. doi: 10.1007/BF01966502. [DOI] [PubMed] [Google Scholar]
  42. Robert A. Antisecretory, antiulcer, cytoprotective and diarrheogenic properties of prostaglandins. Adv Prostaglandin Thromboxane Res. 1976;2:507–520. [PubMed] [Google Scholar]
  43. Robert A., Böttcher W., Golanska E., Kauffman G. L., Jr Lack of correlation between mucus gel thickness and gastric cytoprotection in rats. Gastroenterology. 1984 Apr;86(4):670–674. [PubMed] [Google Scholar]
  44. Robert A., Mylander B., Andersson S. Marked inhibition of gastric secretion by two prostaglandin analogs given orally to man. Life Sci. 1974 Feb 1;14(3):533–538. doi: 10.1016/0024-3205(74)90367-1. [DOI] [PubMed] [Google Scholar]
  45. Robert A., Nezamis J. E., Lancaster C., Hanchar A. J. Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology. 1979 Sep;77(3):433–443. [PubMed] [Google Scholar]
  46. Robert A., Nezamis J. E., Phillips J. P. Effect of prostaglandin E1 on gastric secretion and ulcer formation in the rat. Gastroenterology. 1968 Oct;55(4):481–487. [PubMed] [Google Scholar]
  47. Robert A., Nezamis J. E., Phillips J. P. Inhibition of gastric secretion by prostaglandins. Am J Dig Dis. 1967 Oct;12(10):1073–1076. doi: 10.1007/BF02233268. [DOI] [PubMed] [Google Scholar]
  48. Robinson M. G., Griffin J. W., Jr, Bowers J., Kogan F. J., Kogut D. G., Lanza F. L., Warner C. W. Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal antiinflammatory drugs. Dig Dis Sci. 1989 Mar;34(3):424–428. doi: 10.1007/BF01536266. [DOI] [PubMed] [Google Scholar]
  49. Roth S., Agrawal N., Mahowald M., Montoya H., Robbins D., Miller S., Nutting E., Woods E., Crager M., Nissen C. Misoprostol heals gastroduodenal injury in patients with rheumatoid arthritis receiving aspirin. Arch Intern Med. 1989 Apr;149(4):775–779. [PubMed] [Google Scholar]
  50. Roth S., Agrawal N., Mahowald M., Montoya H., Robbins D., Miller S., Nutting E., Woods E., Crager M., Nissen C. Misoprostol heals gastroduodenal injury in patients with rheumatoid arthritis receiving aspirin. Arch Intern Med. 1989 Apr;149(4):775–779. [PubMed] [Google Scholar]
  51. Salvemini D., Misko T. P., Masferrer J. L., Seibert K., Currie M. G., Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci U S A. 1993 Aug 1;90(15):7240–7244. doi: 10.1073/pnas.90.15.7240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Sarosiek J., Murty V. L., Nadziejko C., Slomiany A., Slomiany B. L. Prostaglandin effect on the physical properties of gastric mucus glycoprotein and its susceptibility to pepsin. Prostaglandins. 1986 Nov;32(5):635–646. doi: 10.1016/0090-6980(86)90186-3. [DOI] [PubMed] [Google Scholar]
  53. Sellers L. A., Carroll N. J., Allen A. Misoprostol-induced increases in adherent gastric mucus thickness and luminal mucus output. Dig Dis Sci. 1986 Feb;31(2 Suppl):91S–95S. doi: 10.1007/BF01309330. [DOI] [PubMed] [Google Scholar]
  54. Shah K., Price A. B., Talbot I. C., Bardhan K. D., Fenn C. G., Bjarnason I. Effect of longterm misoprostol coadministration with non-steroidal anti-inflammatory drugs: a histological study. Gut. 1995 Aug;37(2):195–198. doi: 10.1136/gut.37.2.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Sharon P., Cohen F., Zifroni A., Karmeli F., Ligumsky M., Rachmilewitz D. Prostanoid synthesis by cultured gastric and duodenal mucosa: Possible role in the pathogenesis of duodenal ulcer. Scand J Gastroenterol. 1983 Nov;18(8):1045–1049. doi: 10.3109/00365528309181838. [DOI] [PubMed] [Google Scholar]
  56. Silverstein F. E., Graham D. Y., Senior J. R., Davies H. W., Struthers B. J., Bittman R. M., Geis G. S. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1995 Aug 15;123(4):241–249. doi: 10.7326/0003-4819-123-4-199508150-00001. [DOI] [PubMed] [Google Scholar]
  57. Somerville K., Faulkner G., Langman M. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet. 1986 Mar 1;1(8479):462–464. doi: 10.1016/s0140-6736(86)92927-2. [DOI] [PubMed] [Google Scholar]
  58. Stern A. I., Ward F., Sievert W. Lack of gastric mucosal protection by sucralfate during long-term aspirin ingestion in humans. Am J Med. 1989 Jun 9;86(6A):66–69. doi: 10.1016/0002-9343(89)90160-5. [DOI] [PubMed] [Google Scholar]
  59. Szabo S., Trier J. S., Brown A., Schnoor J. Early vascular injury and increased vascular permeability in gastric mucosal injury caused by ethanol in the rat. Gastroenterology. 1985 Jan;88(1 Pt 2):228–236. doi: 10.1016/s0016-5085(85)80176-1. [DOI] [PubMed] [Google Scholar]
  60. Tao P., Wilson D. E. Effects of prostaglandin E2, 16,16-dimethyl prostaglandin E2 and a prostaglandin endoperoxide analogue (U-46619) on gastric secretory volume, [H+] and mucus synthesis and secretion in the rat. Prostaglandins. 1984 Sep;28(3):353–365. doi: 10.1016/0090-6980(84)90022-4. [DOI] [PubMed] [Google Scholar]
  61. Tarnawski A., Hollander D., Stachura J., Krause W. J., Gergely H. Prostaglandin protection of the gastric mucosa against alcohol injury--a dynamic time-related process. Role of the mucosal proliferative zone. Gastroenterology. 1985 Jan;88(1 Pt 2):334–352. doi: 10.1016/s0016-5085(85)80188-8. [DOI] [PubMed] [Google Scholar]
  62. Vane J. Towards a better aspirin. Nature. 1994 Jan 20;367(6460):215–216. doi: 10.1038/367215a0. [DOI] [PubMed] [Google Scholar]
  63. Wallace J. L., McKnight G. W., Keenan C. M., Byles N. I., MacNaughton W. K. Effects of leukotrienes on susceptibility of the rat stomach to damage and investigation of the mechanism of action. Gastroenterology. 1990 May;98(5 Pt 1):1178–1186. doi: 10.1016/0016-5085(90)90331-t. [DOI] [PubMed] [Google Scholar]
  64. Wallace J. L., Reuter B., Cicala C., McKnight W., Grisham M. B., Cirino G. Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat. Gastroenterology. 1994 Jul;107(1):173–179. doi: 10.1016/0016-5085(94)90074-4. [DOI] [PubMed] [Google Scholar]
  65. Wallace J. L., Reuter B., Cicala C., McKnight W., Grisham M., Cirino G. A diclofenac derivative without ulcerogenic properties. Eur J Pharmacol. 1994 May 23;257(3):249–255. doi: 10.1016/0014-2999(94)90136-8. [DOI] [PubMed] [Google Scholar]
  66. Whittle B. J., Lopez-Belmonte J., Moncada S. Regulation of gastric mucosal integrity by endogenous nitric oxide: interactions with prostanoids and sensory neuropeptides in the rat. Br J Pharmacol. 1990 Mar;99(3):607–611. doi: 10.1111/j.1476-5381.1990.tb12977.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Wilson D. E., Phillips C., Levine R. A. Inhibition of gastric secretion in man by prostaglandin A. Gastroenterology. 1971 Aug;61(2):201–206. [PubMed] [Google Scholar]
  68. Wilson D. E., Quadros E., Rajapaksa T., Adams A., Noar M. Effects of misoprostol on gastric acid and mucus secretion in man. Dig Dis Sci. 1986 Feb;31(2 Suppl):126S–129S. doi: 10.1007/BF01309336. [DOI] [PubMed] [Google Scholar]
  69. Wilson D. E., Winnan G., Quertermus J., Tao P. Effects of an orally administered prostaglandin analogue (16, 16-dimethyl prostaglandin E2) on human gastric secretion. Gastroenterology. 1975 Sep;69(3):607–611. [PubMed] [Google Scholar]
  70. Yokoyama C., Tanabe T. Cloning of human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzyme. Biochem Biophys Res Commun. 1989 Dec 15;165(2):888–894. doi: 10.1016/s0006-291x(89)80049-x. [DOI] [PubMed] [Google Scholar]

Articles from Transactions of the American Clinical and Climatological Association are provided here courtesy of American Clinical and Climatological Association

RESOURCES